Novartis Zelmac Dosing Instructions Among Remaining Issues In FDA Review

FDA will have to decide between a high dose or titrated regimen for Novartis' irritable bowel syndrome therapy Zelmac following a review by the Gastrointestinal Drugs Advisory Committee.